Merck’s Prinivil (lisinopril)
Executive Summary
ACE inhibitor approved June 14 for adjunctive therapy in the management of congestive heart failure in patients not responding adequately to conventional therapy. Zeneca's lisinopril (Zestril) was approved for the same indication June 11 ("The Pink Sheet" June 14, In Brief).